Methods for the detection of adverse drug reactions in hospitalized children: a systematic review

被引:5
作者
Ramos, Sheila Feitosa [1 ,2 ]
Alvarez, Nathalia Rodrigues [3 ]
dos Santos Alcantara, Thaciana [1 ]
Sanchez, Julia Mirao [1 ]
da Costa Lima, Elisangela [3 ]
de Lyra Junior, Divaldo Pereira [1 ,2 ]
机构
[1] Univ Fed Sergipe, Dept Pharm, Lab Teaching & Res Social Pharm LEPFS UFS, Sao Cristovao, SE, Brazil
[2] Univ Fed Sergipe, Hlth Sci Grad Program, Prorectory Res & Postgrad, Sao Cristovao, Brazil
[3] Univ Fed Rio de Janeiro, Dept Pharm, Rio De Janeiro, Brazil
关键词
Adverse drug reactions; hospitals; children; systematic review; pharmacovigilance; pediatrics; HEALTH-CARE PROFESSIONALS; MEDICINE USE; PHARMACOVIGILANCE; SAFETY; KNOWLEDGE; IDENTIFICATION; INTERVENTION; EPIDEMIOLOGY; SURVEILLANCE; ALGORITHM;
D O I
10.1080/14740338.2021.1924668
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Adverse drug reactions (ADR) are a problem for healthcare systems worldwide. Pediatric patients constitute a vulnerable group with regard to ADRs. However, although pediatric patients are at increased risk for these reactions, there is little progress on ADR detection methods in this group. Areas covered: In this systematic search, performed according to PRISMA statements, we selected studies, published in PubMed/Medline databases; Scopus; LILACS; Web of Science; Embase and Cochrane Library until April, 2020, on ADRs in hospitalized pediatric patients. Expert opinion: The increase of pediatric drug safety data is essential to the improvement of childcare. Health services must continuously stimulate educational programs focused on ADR detection tools to minimize the barriers and raise awareness among professionals. Therefore, it is necessary to consider that each method has advantages and disadvantages and must be analyzed in detail to be implemented according to the peculiarities of each practice scenario. Triggers tools (active method) correlated with electronic medical notes seems a good strategy for ADR identification, whether pediatric parameters are well checked and adapted with each age group. In any event, combined methods will add data to identification and clearer ADR assessment.
引用
收藏
页码:1225 / 1236
页数:12
相关论文
共 88 条
[1]  
Aagaard L, 2012, DRUG SAFETY, V35, P1171, DOI 10.2165/11631940-000000000-00000
[2]   Information about adverse drug reactions reported in children: a qualitative review of empirical studies [J].
Aagaard, Lise ;
Christensen, Arne ;
Hansen, Ebba Holme .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (04) :481-491
[3]  
Adverse Drug, 2019, J PEDIAT PHARM THER, V24, P4
[4]  
Al Aloola, 2020, PLOS ONE, P15
[5]   Epidemiology, comparative methods of detection, and preventability of adverse drug events [J].
Al-Tajir, GK ;
Kelly, WN .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) :1169-1174
[6]  
Aleena A., 2018, ASIAN J PHARM CLIN R, V11, P3
[7]   Adverse drug reactions in neonates and infants: a population-tailored approach is needed [J].
Allegaert, Karel ;
van den Anker, Johannes N. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) :788-795
[8]   Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia [J].
Alwhaibi, Monira ;
Alhindi, Ghaida ;
Alshamrani, Majd ;
Bin Essa, Maryam ;
Al Aloola, Noha A. ;
Alhawassi, Tariq M. .
BMC MEDICAL EDUCATION, 2020, 20 (01)
[9]  
Amin Saloni, 2018, Perspect Clin Res, V9, P70, DOI 10.4103/picr.PICR_64_17
[10]   Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBaseA® [J].
Ampadu, Haggar H. ;
Hoekman, Jarno ;
de Bruin, Marieke L. ;
Pal, Shanthi N. ;
Olsson, Sten ;
Sartori, Daniele ;
Leufkens, Hubert G. M. ;
Dodoo, Alexander N. O. .
DRUG SAFETY, 2016, 39 (04) :335-345